A Study of Atezolizumab in Combination With Bevacizumab in Patients With EGFR Mutation Positive Stage IIIB-IV Non-Squamous Non-Small Cell Lung Cancer
Clinical trial NCT04426825 · COMPLETED
Trial details
- NCT number
- NCT04426825
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-09
- Primary completion
- 2022-01-19
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.